Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial (Q42010275)

15 October 2017

title

Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial (English)

1 reference

15 October 2017

2

Poynard T

1 reference

15 October 2017

Lebrec D

1

1 reference

15 October 2017

Capron JP

3

1 reference

15 October 2017

Hillon P

4

1 reference

15 October 2017

Geoffroy P

5

1 reference

15 October 2017

Roulot D

6

1 reference

15 October 2017

Chaput JC

7

1 reference

15 October 2017

Rueff B

8

1 reference

15 October 2017

Benhamou JP

9

1 reference

15 October 2017

publication date

1 August 1988

1 reference

15 October 2017

published in

Journal of Hepatology

1 reference

15 October 2017

volume

7

1 reference

15 October 2017

issue

1

1 reference

15 October 2017

page(s)

118-125

1 reference

Propranolol--a medical treatment for portal hypertension?

15 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Short-term effects of propranolol on portal venous pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Propranolol for gastrointestinal bleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

A controlled study of the prophylactic portacaval shunt. A final report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Prophylactic portacaval anastomosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Prophylactic sclerosing of esophageal varices--results of a prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

A randomized clinical trial of propranolol for the prevention of initial bleeding in cirrhosis with portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980515-4

7 January 2021

10.1016/S0168-8278(88)80515-4

Identifiers

DOI

1 reference

15 October 2017

1 reference